{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:



Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

9th Annual MSK Symposium on Lymphoma


9th Annual MSK Symposium on Lymphoma Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Accommodations
  • Exhibitors
  • Support
Add to Calendar 9th Annual MSK Symposium on Lymphoma 4/25/2025 8:00:00 AM 4/26/2025 12:55:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=53462 Description: This annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking d... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Friday, April 25, 2025, 8:00 AM - Saturday, April 26, 2025, 12:55 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Anatomic Pathology, Bone Marrow Transplant, Cellular Therapeutics, Clinical Pathology, Geriatric Medicine, Hematology, Hematopathology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Molecular Pathology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology

Overview

This annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking drug developments that are redefining patient care. Attendees will gain valuable insights into the latest findings in lymphoma biology and pathology, exploring how these breakthroughs are being translated into practical, impactful solutions for clinical practice.

This year's program, spanning a day and a half, features:

— Keynote Lectures: Featuring renowned leaders in lymphoma research and care.
— Interactive Panel Discussions: Practical discussions on innovative approaches to advancing patient outcomes.
— Empowering APPs and Nurses: Professional Development Breakout Session (In-Person Only): Tailored content for interprofessional teams, emphasizing their pivotal role in advancing lymphoma treatment. This breakout session will held on the afternoon of Friday, April 25.
— Networking Opportunities (In-Person Only): Connect with colleagues and faculty during breaks as well as a dedicated Welcome Reception on the evening of Friday, April 25, and a Farewell Lunch Reception on Saturday, April 26. Please RSVP during registration if you plan to attend either reception.

Additionally, attendees will gain access to an online syllabus following the symposium, which will include select PDFs of faculty presentations (slides) and recorded videos. Please note, if you are unable to attend the Nursing and APP Breakout Session in person, it will be recorded and made available through the syllabus after the event.

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the choice of attending either in-person or virtually.

We look forward to welcoming colleagues and esteemed faculty from around the world to exchange insights and advance the future of lymphoma care.

Objectives
At the conclusion of this symposium, attendees will be able to:

  1. Describe recent advances in lymphoma classification
  2. Discuss first line treatment options in most frequent lymphoma entities
  3. Describe new agents mode of actions, efficacy, side effects
  4. Discuss options and recommendations for patients in the relapse refractory setting
  5. Provide adequate information to help shared decision with patients regarding their treatment

Registration

This symposium offers participants the choice of attending either in person or virtually. In-person registration includes continental breakfast, lunch, refreshment breaks, and a complimentary invitation to both the networking receptions. Please contact [email protected] at least one week prior to the symposium if you have any special dietary requests or require any specific accommodations.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Rates 

— Physicians (MDs, PhDs, and DOs): $450
— Advanced Practice Providers: $200
— Nurses and Other Healthcare Providers: $150
— Residents and Fellows: $100*
— Industry Professionals: $785**
— MSK Employees: Complimentary

*The resident and fellow rate is non-refundable for in-person registration.
**An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

For details on our cancellation terms, please review our Cancellation Policy.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

— 13.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
— 13.00 Lifelong Learning (CME) credits in the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit.

ANCC CNE Statement

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

13.00 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.



Keywords: ABIM MOCAMA PRA Category 1Nursing Credit ABPath CCIn-PersonVirtual


Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for course attendees.



 

MSK Symposium Director

Gilles Salles, MD, PhD
Chief, Lymphoma Service

 

MSK Planning Committee

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service

Lauren Drosick, PA-C
Advanced Practice Provider

Kojo S.J. Elenitoba-Johnson, MD
Chair, Department of Pathology and Laboratory Medicine 

Sean E. Healton, MD, PhD
Hematology/Oncology Fellow

Steven Horwitz, MD
Attending Physician, Lymphoma Service

Andrew Intlekofer, MD, PhD
Assistant Member, Human Oncology & Pathogenesis Program

Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma  Service

Ariela Noy, MD
Member, Lymphoma Service

Hans-Guido Wendel, MD
Member/Professor, Cancer Biology and Genetics Program

Joachim Yahalom, MD, FACR, FASTRO
Attending Radiation Oncologist, External Beam Radiotherapy Service

Andrew D. Zelenetz, MD, PhD 
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service 

 

Invited Faculty 

Christopher R. Flowers, MD, MS
Division Head, Division of Cancer Medicine;
Chair, Professor, Department of Lymphoma/Myeloma
MD Anderson Cancer Center 
Houston, TX

Georg Lenz, MD
Professor of Medicine;
Director Department of Hematology, Oncology and Pneumology
University Hospital Münster
Münster Germany

Brian K. Link, MD
Professor Emeritus of Internal Medicine - Hematology, Oncology, and Blood & Marrow Transplantation 
University of Iowa College of Medicine
Iowa City, IA

Kami J. Maddocks, MD
Professor in the College of Medicine 
The Ohio State University
Columbus, OH

David G. Maloney, MD, PhD
Fred Hutchinson Cancer Research Center 
University of Washington
Seattle, WA

Coraline Mlynarczyk, PhD
Assistant Professor of Medicine (Hematology) 
Yale School of Medicine
New Haven, CT

Laura Pasqualucci, MD
Professor of Pathology and Cell Biology 
Columbia University
New York, NY 

Barbara Pro, MD
Professor of Medicine;
Director of Lymphoma Program
Herbert Irving Comprehensive Cancer Center
New York, NY 

Sandrine Roulland, PharmD, PhD
Inserm Research Director
Centre d’Immunologie de Marseille Luminy
Marseille, France

Sarah Rutherford, MD
Associate Professor of Clinical Medicine
Weill Cornell Medicine
New York, NY

Clémentine Sarkozy, MD, PhD
Institut Curie
Paris, France

Margaret A. Shipp, MD
Chief, Division of Hematologic Neoplasia, Dana Farber Cancer Institute;
Professor of Medicine, Harvard Medical School 
Boston, MA


MSK Faculty 

Ashley Ames, MSN, RN, FNP-BC
Advanced Practice Provider

Annalisa Benz, BSN, RN, OCN
Clinical Nurse III

Alexander P. Boardman, MD
Assistant Attending Physician, Lymphoma Service

Theresa Davey, PA
Advanced Practice Provider


Zachary Epstein-Peterson, MD
Attending Physician, Lymphoma Service 

Lorenzo Falchi, MD
Assistant Attending Physician, Lymphoma Service

Jennifer Gorelov, AGNP-BC, MSN
Advanced Practice Provider


Dana Guerra, BSN, RN
Clinical Nurse II

Paul A. Hamlin, MD
Attending Physician, Lymphoma Service

Brandon Imber, MD, MA
Assistant Attending Radiation Oncologist, External Beam Radiotherapy Service

Anita Kumar, MD
Associate Attending Physician, Lymphoma Service 

Efrat Luttwak, MD, MPH
Assistant Attending Physician, Lymphoma Service 

Ivan Maillard, MD, PhD
Attending Physician, Leukemia Service;
Head of the Division of Hematologic Malignancies

Joanna Mi, MSN, AGPCNP-BC, AOCNP® 
Advanced Practice Provider


M. Lia Palomba, MD
Member, Lymphoma Service and Cellular Therapeutics Service

Shenon Sethi, MBBS
Assistant Attending Pathologist, Hematopathology Service

Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant and See all Cellular Therapy Services

Marcel Smith, MSN, FNP, MSPharm, AOCNP
Advanced Practice Provider


Emily Spevack, BSN, RN, OCN®
Clinical Nurse III

Raphael Steiner, MD
Associate Attending Physician, Lymphoma Service 

Robert Stuver, MD
Assistant Attending Physician, Lymphoma Service 

Pallawi Torka, MD
Assistant Attending Physician, Lymphoma Service 

Jasmine M. Zain, MD
Lymphoma Service

Ting Zhou, MD
Assistant Attending Pathologist, Hematopathology Service



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Gilles Salles, MD, PhD
MSK
Activity Director, Faculty
Advisor-Abbvie|Review Panel Member-Beigene|Advisor-Bristol-Myers Squibb|Consulting Fee-Epizyme (Relationship has ended)|Advisor-Genentech, Inc.|Advisor-Genmab|Advisor-Incyte Corporation (Relationship has ended)|Advisor-Janssen|Honoraria-Gilead (Relationship has ended)|Consulting Fee-Eli Lilly and Company (Relationship has ended)|Consulting Fee-Novartis AG|Consulting Fee-Nurix (Relationship has ended)|Consulting Fee-IPSEN|Honoraria-Merck and Company, Inc. (Relationship has ended)|Consulting Fee-Foresight (Relationship has ended)|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Consulting Fee-SERB Pharmaceutical (Relationship has ended)|Advisor-Ellipses|Advisor-Innate Pharma (Relationship has ended)|Consulting Fee-Modex (Relationship has ended)|Consulting Fee-Orna Therapeutics (Relationship has ended)|Consulting Fee-Treeline (Relationship has ended)|Grant or research support-Abbvie|Grant or research support-Genentech, Inc.|Grant or research support-Genmab|Grant or research support-Ipsen|Grant or research support-Janssen
Andrew Intlekofer, MD
MSK
Conflict of Interest Peer Reviewer, Faculty, Planner
Nothing to disclose
Joselin Galvez, BS
MSKCC
Department Support (manager, assistant, etc)
Nothing to disclose
Ashley Ames, FNP-BC, NP
MSK
Faculty
Nothing to disclose
Annalisa Benz, BSN, RN, OCN
MSK
Faculty
Nothing to disclose
Alexander Paul Boardman, MD
MSK
Faculty
Consulting Fee-Bristol-Myers Squibb
Theresa Davey, PA
MSK
Faculty
Nothing to disclose
Zachary D Epstein-Peterson, MD
MSK
Faculty
Advisor-Genmab (Relationship has ended)|Honoraria-BioPharm Communications (Relationship has ended)
Faculty Photos
Lorenzo Falchi, MD
MSK
Faculty
Grant or research support-Genmab|Consulting Fee-Genmab|Grant or research support-Roche|Consulting Fee-Roche|Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Consulting Fee-Abbvie|Grant or research support-Abbvie|Advisor-ADC Therapeutics (Relationship has ended)|Grant or research support-AstraZeneca|Advisor-Ipsen (Relationship has ended)|Grant or research support-Innate|Consulting Fee-Sanofi-Aventis (Relationship has ended)|Consulting Fee-Merck and Company, Inc.
Christopher Flowers, MD, MS, FASCO
MD Anderson Cancer Center
Faculty
Consulting Fee-Abbvie|Consulting Fee-Bayer Corporation|Consulting Fee-BeiGene|Consulting Fee-Celgene|Consulting Fee-Denovo Biopharma|Consulting Fee-Foresight Diagnostics|Consulting Fee-Genentech, Inc.|Consulting Fee-Genmab|Consulting Fee-Gilead|Consulting Fee-Karyopharm|Consulting Fee-N-Power Medicine|Consulting Fee-Pharmacyclics, Inc.|Consulting Fee-SeaGen|Consulting Fee-Spectrum|Stocks or stock options, excluding diversified mutual funds-Foresight Diagnostics|Stocks or stock options, excluding diversified mutual funds-N-Power Medicine|Grant or research support-4D|Grant or research support-Abbvie|Grant or research support-Acerta|Grant or research support-Adaptimmune|Grant or research support-Allogene|Grant or research support-Amgen|Grant or research support-Bayer Corporation|Grant or research support-BostonGene|Grant or research support-Celgene|Grant or research support-Cellectis EMD|Grant or research support-Gilead|Grant or research support-Genentech, Inc.|Grant or research support-Guardant|Grant or research support-Iovance|Grant or research support-Janssen Pharmaceutical|Grant or research support-Kite|Grant or research support-Morphosys|Grant or research support-Nektar|Grant or research support-Novartis AG|Grant or research support-Pfizer, Inc.|Grant or research support-Pharmacyclics, Inc.|Grant or research support-Sanofi-Aventis|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-TG Therapeutics|Grant or research support-Xencor|Grant or research support-Ziopharm
Jennifer Gorelov, NP
MSK
Faculty
Nothing to disclose
Dana Guerra, BSN, RN
MSK
Faculty
Nothing to disclose
Paul A Hamlin, MD
MSK
Faculty
Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Beigene (Relationship has ended)|Consulting Fee-ADC Therapeutics (Relationship has ended)|Consulting Fee-Karyopharm (Relationship has ended)|Grant or research support-Janssen
Brandon Imber, MD
MSK
Faculty
Honoraria-GT Medical Technologies|Grant or research support-Novartis AG|Grant or research support-Bayer Corporation (Relationship has ended)|Grant or research support-AstraZeneca|Grant or research support-Kazia|Honoraria-Telix (Relationship has ended)
Anita Kumar, MD
MSK
Faculty
Advisor-AstraZeneca|Consulting Fee-Genentech, Inc.|Advisor-Kite Pharmaceuticals (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Grant or research support-Seattle Genetics|Grant or research support-Adaptive Biotechnologies|Grant or research support-Loxo Biotechnologies |Grant or research support-Celgene|Grant or research support-Incyte Corporation
Carissa Laudati
MSK
Faculty
Advisor-Genmab (Relationship has ended)
Georg Lenz, MD
University of Munster
Germany
Faculty
Advisor-Abbvie|Consulting Fee-Abbvie|Grant or research support-Abbvie|Speakers Bureau-Abbvie (Relationship has ended)|Advisor-Bristol-Myers Squibb|Speakers Bureau-Bristol-Myers Squibb (Relationship has ended)|Advisor-AstraZeneca|Grant or research support-AstraZeneca (Relationship has ended)|Advisor-Novartis AG (Relationship has ended)|Advisor-Gilead (Relationship has ended)|Grant or research support-Gilead|Advisor-Roche|Advisor-Incyte Corporation|Speakers Bureau-Incyte Corporation|Advisor-Eli Lilly and Company
Brian Link, MD
University of Iowa College of Medicine
Faculty
Grant or research support-Genentech, Inc.|Grant or research support-AstraZeneca|Grant or research support-Abbvie
Efrat Luttwak, MD
MSK
Faculty
Nothing to disclose
Kami Maddocks, MD
The Ohio State University Comprehensive Cancer Center
Faculty
Consulting Fee-Abbvie|Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-Gilead (Relationship has ended)|Consulting Fee-Incyte Corporation|Consulting Fee-Pfizer, Inc. (Relationship has ended)
Ivan Maillard, MD, PhD
MSK
Faculty
Advisor-Garuda Therapeutics (Relationship has ended)|Grant or research support-Regeneron (Relationship has ended)|Grant or research support-Genentech, Inc. (Relationship has ended)|Honoraria-Gilead (Relationship has ended)
David G. Maloney, MD, PhD
Fred Hutchinson Cancer Research Center
Faculty
Advisor-A2 Biotherapeutics|Stocks or stock options, excluding diversified mutual funds-A2 Biotherapeutics|Stocks or stock options, excluding diversified mutual funds-Achieve clinics |Consulting Fee-Artiva Bio|Advisor-Bristol-Myers Squibb|Advisor-Caribou|Advisor-Chimeric|Advisor-Genentech, Inc.|Advisor-Gilead|Advisor-Iterius Bio|Stocks or stock options, excluding diversified mutual funds-Navan|Advisor-Novartis AG|Advisor-Umoja
Joanna Mi, MSN|NP
MSK
Faculty
Nothing to disclose
Coraline Mlynarczyk, PhD
Yale School of Medicine
Faculty
Nothing to disclose
Lia Palomba, MD
MSK
Faculty
Advisor-Synthekine (Relationship has ended)|Advisor-Bristol-Myers Squibb|Advisor-MustangBio (Relationship has ended)|Advisor-Novartis AG|Advisor-BeiGene
Laura Pasqualucci, MD
Columbia University VagelosCollege of Physician & Surgeons
Faculty
Grant or research support-AstraZeneca (Relationship has ended)
Barbara Pro, MD
Columbia University Irving Medical Center
Faculty
Advisor-Secura Bio|Grant or research support-ONO|Grant or research support-Scitech
Sandrine Roulland, PharmD, PhD
Centre d’Immunologie de Marseille Luminy
France
Faculty
Grant or research support-Bristol-Myers Squibb
Sarah C. Rutherford, MD
Weill Cornell Medicine
Faculty
Consulting Fee-Abbvie|Consulting Fee-Kite|Consulting Fee-Bristol-Myers Squibb|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Consulting Fee-Incyte Corporation|Consulting Fee-Pfizer, Inc.|Consulting Fee-ADC|Consulting Fee-Genmab|Consulting Fee-Kite|Consulting Fee-Karyopharm|Grant or research support-Karyopharm (Relationship has ended)|Grant or research support-Constellation (Relationship has ended)
Clementine Sarkozy, MD, PhD, Doctor
Curie Institute
France
Faculty
Consulting Fee-Abbvie (Relationship has ended)|Consulting Fee-Roche (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Advisor-Johnson and Johnson
Shenon Sethi, MD
MSK
Faculty
Nothing to disclose
Gunjan Shah , MD, MS
MSK
Faculty
Grant or research support-Johnson and Johnson|Grant or research support-Amgen|Grant or research support-Beyond Spring|Grant or research support-Bristol-Myers Squibb|Grant or research support-GPCR Therapeutics|Review Panel Member-Arcellx
Margaret Shipp, MD
Dana-Farber Cancer Institute
Faculty
Grant or research support-Bristol-Myers Squibb|Grant or research support-Merck and Company, Inc.|Advisor-Immunitas Therapeutics (Relationship has ended)|Grant or research support-Bayer Corporation|Grant or research support-Abbvie|Advisor-AstraZeneca|Advisor-AstraZeneca
Marcel Smith, FNP-BC
MSK
Faculty
Nothing to disclose
Emily Spevack, BSN
MSK
Faculty
Nothing to disclose
Raphael E Steiner , MD
MSK
Faculty
Grant or research support-Pfizer, Inc. (Relationship has ended)|Grant or research support-Bristol-Myers Squibb (Relationship has ended)|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Rafael Pharmaceuticals (Relationship has ended)
Robert Stuver, MD
MSK
Faculty
Grant or research support-Pfizer, Inc.|Grant or research support-Step Pharma
Pallawi Torka, MD
MSK
Faculty
Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-Abbvie (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Consulting Fee-Seagen (Relationship has ended)|Consulting Fee-TG therapeutics (Relationship has ended)|Consulting Fee-ADC therapeutics (Relationship has ended)|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-Eli Lilly and Company (Relationship has ended)
Jasmine Zain, MD
MSK
Faculty
Grant or research support-Daiichi Sankyo (Relationship has ended)|Grant or research support-Myeloid (Relationship has ended)|Grant or research support-CRSPR (Relationship has ended)|Grant or research support-Astex (Relationship has ended)|Advisor-Kiowa Kirin (Relationship has ended)|Grant or research support-Dren Bio (Relationship has ended)|Grant or research support-Ymabs Therapeutics (Relationship has ended)
Ting Zhou, MD, PhD
MSK
Faculty
Nothing to disclose
Ahmet Dogan, MD, PhD
MSK
Faculty, Planner
Grant or research support-Roche (Relationship has ended)|Grant or research support-AstraZeneca
Lauren Drosick, PA-C
MSK
Faculty, Planner
Nothing to disclose
Kojo Elenitoba-Johnson, MD
MSK
Faculty, Planner
Nothing to disclose
Steven Horwitz, MD
MSK
Faculty, Planner
Grant or research support-Kyowa|Grant or research support-Treeline|Consulting Fee-Treeline|Consulting Fee-SymBio (Relationship has ended)|Consulting Fee-Johnson and Johnson|Consulting Fee-Kyowa|Consulting Fee-Affimed (Relationship has ended)|Consulting Fee-TUBULIS (Relationship has ended)|Consulting Fee-Takeda Pharmaceuticals, Inc.|Grant or research support-Secura|Consulting Fee-Secura|Consulting Fee-Ono|Grant or research support-Daiichi Sankyo|Consulting Fee-Daiichi Sankyo (Relationship has ended)|Grant or research support-Crispr|Grant or research support-C4|Consulting Fee-Yingli (Relationship has ended)|Consulting Fee-Abcuro (Relationship has ended)|Consulting Fee-Autolus (Relationship has ended)|Consulting Fee-Auxilius Pharma (Relationship has ended)|Consulting Fee-CTI Bio Pharma Group (Relationship has ended)|Consulting Fee-Dren Bio|Consulting Fee-Seagen|Grant or research support-Seagen|Grant or research support-Trillium (Relationship has ended)|Grant or research support-Affimed (Relationship has ended)|Grant or research support-Takeda Millenium (Relationship has ended)|Consulting Fee-March Biosciences|Consulting Fee-Corvus Pharmaceuticals
Alison Moskowitz, MD
MSK
Faculty, Planner
Grant or research support-Seagen|Grant or research support-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Incyte Corporation|Grant or research support-SecuraBio|Honoraria-Seagen|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Merck and Company, Inc.|Honoraria-Affimed|Grant or research support-AstraZeneca
Ariela Noy, MD
MSK
Faculty, Planner
Consulting Fee-Epizyme (Relationship has ended)|Grant or research support-Johnson and Johnson|Consulting Fee-Cleariew|Consulting Fee-Johnson and Johnson|Other: Research funding-Abbvie|Other: Research funding-Cornerstone Pharma|Advisor-Morphosys (Relationship has ended)|Advisor-AstraZeneca|Grant or research support-Gilead|Advisor-kite Pharma (Relationship has ended)|Honoraria-EUSA (Relationship has ended)|Honoraria-Recordati|Advisor-tg therapeutics (Relationship has ended)|Advisor-ADC therapeutics (Relationship has ended)|Consulting Fee-beigene (Relationship has ended)|Honoraria-DAVA (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Consulting Fee-Guidepoint Global (Relationship has ended)
Hans-Guido Wendel, MD
MSK
Faculty, Planner
Nothing to disclose
Joachim Yahalom, MD
MSK
Faculty, Planner
Nothing to disclose
Andrew D Zelenetz, MD, PhD
MSK
Faculty, Planner
Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Consulting Fee-Roche|Advisor-Bristol-Myers Squibb|Consulting Fee-Gilead|Consulting Fee-AstraZeneca|Grant or research support-Beigene|Consulting Fee-Beigene|Consulting Fee-Novartis AG|Consulting Fee-Abbvie|Consulting Fee-MorphoSys|Other: DMC Member-Bristol-Myers Squibb|Advisor-IPSEN|Advisor-Ono|Advisor-Arvinas|Grant or research support-Arvinas
Sean E Healton, MD, PhD
MSK
Faculty, Resident/Fellow Planner
Nothing to disclose
Anastasia Martinova, BSN
MSK
Nurse Content Expert
Nothing to disclose
Keith Aiello, CCRN
MSKCC
Nurse Planner
Nothing to disclose

Friday, April 25, 2025
Epidemiology and Outcomes of Lymphoma
8:05AM - 9:05AM
Christopher Flowers, MD, MS, FASCO

Treatment Initiation Versus Active Surveillance
9:05AM - 9:35AM
Brian Link, MD

Histologic Transformation of Follicular Lymphoma
9:35AM - 10:05AM
Clementine Sarkozy, MD, PhD, Doctor

New Drugs on the Horizon for Follicular Lymphoma
10:05AM - 10:25AM
Andrew D Zelenetz, MD, PhD

Panel Discussion: Current Challenges in the Management of Patients with Follicular Lymphoma
10:25AM - 10:45AM
Efrat Luttwak, MD (Moderator)
Gilles Salles, MD, PhD (Moderator)

Recent Insights Into Mantle Cell Lymphoma Biology
11:00AM - 11:15AM
Shenon Sethi, MD

Current Dilemma in the First Line Therapy Setting
11:15AM - 11:45AM
Kami Maddocks, MD

Cellular Therapies for Treating Mantle Cell Lymphoma
11:45AM - 12:00PM
Zachary D Epstein-Peterson, MD

Panel Discussion: Advances in Therapeutic Strategies for Mantle Cell Lymphoma
12:00PM - 12:20PM
Ahmet Dogan, MD, PhD (Moderator)
Anita Kumar, MD (Moderator)

Biology of Hodgkin Lymphoma
1:20PM - 2:05PM
Margaret Shipp, MD

The Evolving Standard of Care in First Line
2:05PM - 2:25PM
Robert Stuver, MD

Management of Older Patients
2:25PM - 2:45PM
Sarah C. Rutherford, MD

Options After First Line Treatment Failure
2:45PM - 3:05PM
Alison Moskowitz, MD

Panel Discussion: Hodgkin Lymphoma
3:05PM - 3:25PM
Alison Moskowitz, MD (Moderator)
Raphael E Steiner , MD (Moderator)

Germinal Center Biology
3:40PM - 4:10PM
Laura Pasqualucci, MD

B-Cell Dynamics in the Germinal Center
4:10PM - 4:40PM
Coraline Mlynarczyk, PhD

Notch and Marginal Zone Biology
4:40PM - 5:10PM
Ivan Maillard, MD, PhD

Single Cell Analysis of B-Cell Lymphoma
5:10PM - 5:40PM
Sandrine Roulland, PharmD, PhD

Panel Discussion: The Dark Side of B-Cells
5:40PM - 6:10PM
Sean E Healton, MD, PhD (Moderator)
Andrew Intlekofer, MD (Moderator)

 
Breakout Session: Nursing Professional Development

Mantle Cell Lymphoma in Ambulatory Setting: Focus on Supportive Care and Adverse Event Management
3:45PM - 4:05PM
Carissa Laudati
CAR T-Cell Therapy for B Cell Lymphoma: Approach to Management and Care in the Outpatient Setting
4:05PM - 4:25PM
Ashley Ames, FNP-BC, NP
Dana Guerra, BSN, RN
Emily Spevack, BSN
Research Spotlight: Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering
4:25PM - 4:50PM
Theresa Davey, PA
Marcel Smith, FNP-BC
Management of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma
4:50PM - 5:00PM
Annalisa Benz, BSN, RN, OCN
Lymphoma Survivorship: Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment
5:00PM - 5:20PM
Jennifer Gorelov, NP
Panel Discussion: Empowering APPs and Nurses
5:20PM - 5:40PM
Lauren Drosick, PA-C (Moderator)
Saturday, April 26, 2025
Advances in Biology
8:05AM - 8:20AM
Ting Zhou, MD, PhD

Optimizing First Line Therapy
8:20AM - 8:50AM
Barbara Pro, MD

Advancing Therapeutic Options in the Relapse Setting
8:50AM - 9:10AM
Jasmine Zain, MD

Panel Discussion: Improving Outcomes of Patients with T-Cell Lymphoma
9:10AM - 9:30AM
Zachary D Epstein-Peterson, MD (Moderator)
Steven Horwitz, MD (Moderator)

Pogress in Large B-Cell Lymphoma Management
9:45AM - 10:15AM
Georg Lenz, MD

New Antibodies Engaging Immune Cells
10:15AM - 10:35AM
Lorenzo Falchi, MD

Update on Primary Mediastinal B-Cell Lymphoma
10:35AM - 10:50AM
Raphael E Steiner , MD

Update on Burkitt Lymphoma
10:50AM - 11:05AM
Ariela Noy, MD

Optimizing Patient Selection in 2025
11:05AM - 11:25AM
Lia Palomba, MD

Radiation Therapy and CAR T
11:25AM - 11:45AM
Brandon Imber, MD

Lessons and Challenges
11:45AM - 12:30PM
David G. Maloney, MD, PhD

Panel Discussion: Aggressive B-Cell Lymphoma & Car T-Cell Therapies in Large B-Cell Lymphoma
12:30PM - 1:00PM
Alexander Paul Boardman, MD (Moderator)
Paul A Hamlin, MD (Moderator)
Gunjan Shah , MD, MS (Moderator)
Pallawi Torka, MD (Moderator)


Memorial Sloan Kettering Cancer Center gratefully acknowledges the following organizations for providing medical education grants or financial sponsorship for this symposium:

  • AstraZeneca
  • Genentech
  • Johnson & Johnson


Memorial Sloan Kettering Cancer Center is pleased to announce that the following companies will be exhibiting during this symposium:

  • BeOne Medicines
  • Bristol-Myers Squibb
  • Genentech
  • Genmab
  • Incyte Corporation
  • Pfizer
  • Sobi


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center